MB8 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Moberg Pharma AB (publ)

Watchlist Manager

Watchlist

Price: 0.95 EUR 0.11% Market Closed

Market Cap: €46.3m

	Moberg Pharma AB (publ) F:MB8	SE
	UIE PLC F:I55	MT
F	Fuji Electric Co Ltd OTC:FELTY	JP
A	Automax Motors Ltd TASE:AMX	IL
M	Mitsubishi Estate Co Ltd XBER:MES	JP
	3i Group PLC F:IGQ	UK
A	Abb Ltd SWB:ABJA	CH
	Pharvaris NV NASDAQ:PHVS	NL
T	TransAlta Corp F:TZ1	CA
S	Sinopharm Group Co Ltd F:X2S	CN
S	Shufersal Ltd TASE:SAE	IL
M	Mandalay Resources Corp F:R7X2	CA
	Sajo Sea Food Co Ltd KRX:014710	KR

Profitability Summary

Moberg Pharma AB (publ)'s profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

62%

Strong 3Y Average Gross Margin

62%

Declining Gross Margin

100% > 62%

Negative Operating Margin

-120%

Negative 3Y Average Operating Margin

-1 288%

Operating Margin is Increasing

-10 546% > -120%

Negative Net Margin

-129%

Negative 3Y Average Net Margin

-1 261%

Net Margin is Increasing

-7 848% > -129%

Negative Free Cash Flow Margin

-80%

Negative 3Y Average Free Cash Flow Margin

-562%

Free Cash Flow Margin is Increasing

-10 437% > -80%

Negative ROE

-3%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-16%

Declining ROIC

-4% > -5%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.